Ignite Creation Date:
2025-12-24 @ 11:45 PM
Ignite Modification Date:
2026-04-14 @ 8:25 PM
Study NCT ID:
NCT01230151
Status:
WITHDRAWN
Last Update Posted:
2011-02-18
First Post:
2010-10-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Feasibility Study to Evaluate Deep Brain Stimulation (DBS) Settings for the Treatment of Parkinson's Disease
Sponsor:
Intelect Medical, Inc.
Organization:
Study Overview
Official Title:
Sustained Affect of GUIDE (SAGE):A Software Evaluation Study
Status:
WITHDRAWN
Status Verified Date:
2011-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Sponsor (Intelect Medical, Inc.) was acquired by Boston Scientific and study was canceled.
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SAGE
Brief Summary:
The purpose of this study is to assess the cognitive performance in patients with advanced Parkinson's disease receiving Deep Brain Stimulation (DBS) with settings predetermined clinically to settings derived from a patient-specific computational model.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: